Target Validation Information | |||||
---|---|---|---|---|---|
TTD ID | T61722 | ||||
Target Name | Prostaglandin D2 receptor 2 (PTGDR2) | ||||
Type of Target |
Clinical trial |
||||
Drug Potency against Target | AZD1981 | Drug Info | IC50 = 1.4~4 nM | [8] | |
2-(2,4-diphenylthiazol-5-yl)acetic acid | Drug Info | IC50 = 870 nM | [7] | ||
2-(2-acetyl-4-bromophenoxy)acetic acid | Drug Info | IC50 = 4520 nM | [2] | ||
2-(2-allyl-4-chlorophenoxy)acetic acid | Drug Info | Ki = 5130 nM | [4] | ||
2-(2-benzhydryl-4-phenylthiazol-5-yl)acetic acid | Drug Info | IC50 = 370 nM | [6] | ||
2-(2-benzoyl-4-bromophenoxy)acetic acid | Drug Info | IC50 = 437 nM | [2] | ||
2-(2-cyclohexyl-4-fluorophenoxy)acetic acid | Drug Info | Ki = 446 nM | [4] | ||
2-(2-cyclohexyl-4-methoxyphenoxy)acetic acid | Drug Info | Ki = 782 nM | [4] | ||
2-(2-cyclohexyl-4-methylphenoxy)acetic acid | Drug Info | Ki = 353 nM | [4] | ||
2-(2-cyclohexylphenoxy)acetic acid | Drug Info | Ki = 311 nM | [4] | ||
2-(2-formylphenoxy)acetic acid | Drug Info | IC50 = 1970 nM | [2] | ||
2-(4-bromo-2-(hydroxymethyl)phenoxy)acetic acid | Drug Info | IC50 = 6870 nM | [2] | ||
2-(4-bromo-2-cyclohexylphenoxy)acetic acid | Drug Info | Ki = 83 nM | [4] | ||
2-(4-bromo-2-formylphenoxy)acetic acid | Drug Info | IC50 = 481 nM | [2] | ||
2-(4-bromo-2-tert-butylphenoxy)acetic acid | Drug Info | IC50 = 423 nM | [2] | ||
2-(4-chloro-2-cycloheptylphenoxy)acetic acid | Drug Info | IC50 = 248 nM | [5] | ||
2-(4-chloro-2-cyclohexylphenoxy)acetic acid | Drug Info | Ki = 154 nM | [4] | ||
2-(4-chloro-2-cyclopentylphenoxy)acetic acid | Drug Info | Ki = 150 nM | [4] | ||
2-(4-cyano-2-cyclohexylphenoxy)acetic acid | Drug Info | Ki = 230 nM | [4] | ||
3-(4-chloro-2-cyclohexylphenoxy)propanoic acid | Drug Info | Ki = 799 nM | [4] | ||
4-(4-chloro-2-cyclohexylphenoxy)butanoic acid | Drug Info | Ki = 1990 nM | [4] | ||
L-888607 | Drug Info | Ki = 0.8 nM | [1] | ||
LAROPIPRANT | Drug Info | Ki = 745 nM | [3] | ||
Methyl 2-(4-chloro-2-cyclohexylphenoxy)acetate | Drug Info | Ki = 3280 nM | [4] | ||
References | |||||
REF 1 | Indole-3-acetic acid antagonists of the prostaglandin D2 receptor CRTH2. J Med Chem. 2005 Oct 6;48(20):6174-7. | ||||
REF 2 | Novel selective orally active CRTH2 antagonists for allergic inflammation developed from in silico derived hits. J Med Chem. 2006 Nov 16;49(23):6638-41. | ||||
REF 3 | Discovery of a potent and selective prostaglandin D2 receptor antagonist, [(3R)-4-(4-chloro-benzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydroc... J Med Chem. 2007 Feb 22;50(4):794-806. | ||||
REF 4 | 2-Cycloalkyl phenoxyacetic acid CRTh2 receptor antagonists. Bioorg Med Chem Lett. 2007 Aug 1;17(15):4347-50. | ||||
REF 5 | 7-Azaindole-3-acetic acid derivatives: potent and selective CRTh2 receptor antagonists. Bioorg Med Chem Lett. 2009 Aug 15;19(16):4794-8. | ||||
REF 6 | Novel selective thiazoleacetic acids as CRTH2 antagonists developed from in silico derived hits. Part 2. Bioorg Med Chem Lett. 2010 Feb 1;20(3):1181-5. | ||||
REF 7 | Novel selective thiazoleacetic acids as CRTH2 antagonists developed from in silico derived hits. Part 1. Bioorg Med Chem Lett. 2010 Feb 1;20(3):1177-80. | ||||
REF 8 | Exploration of SAR features by modifications of thiazoleacetic acids as CRTH2 antagonists. Bioorg Med Chem Lett. 2010 Mar 1;20(5):1638-41. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.